AMPD2 | Adenosine monophosphate deaminase 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | Predicted intracellular proteins
| | | | | Expressed in all |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
GFAP | Glial fibrillary acidic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
GKAP1 | G kinase anchoring protein 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
INA | Internexin neuronal intermediate filament protein, alpha | Predicted intracellular proteins
| | | | | Group enriched |
LRPAP1 | Low density lipoprotein receptor-related protein associated protein 1 | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
MARS | Methionyl-tRNA synthetase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
QKI | QKI, KH domain containing, RNA binding | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
RAD18 | RAD18 E3 ubiquitin protein ligase | Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
RCN2 | Reticulocalbin 2, EF-hand calcium binding domain | Predicted secreted proteins
| | | | | Expressed in all |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TXNL1 | Thioredoxin-like 1 | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
UBTF | Upstream binding transcription factor, RNA polymerase I | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
USP11 | Ubiquitin specific peptidase 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |